Expression levels of genes implicated in the working mechanism of lenalidomide predict treatment response in lower risk myelodysplastic syndrome patients

Haematologica. 2024 Oct 10. doi: 10.3324/haematol.2024.286157. Online ahead of print.

Abstract

Not available.